DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dyazide (Hydrochlorothiazide / Triamterene) - Adverse Event Reports - Serious Event

 



Index of reports > Cases resulting in a serious event (10)

     Retinal Detachment (3)Confusional State (1)Hyperkalaemia (1)Nausea (1)Mental Status Changes (1)Pancytopenia (1)Nephrolithiasis (1)Oedema Peripheral (1)Dizziness (1)Self-Medication (1)

Below is the selection of adverse event reports related to Dyazide (Hydrochlorothiazide / Triamterene) that includes cases resulting in a serious event.

Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-19

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Dosage: dosage form: vial.
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-19

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Dosage: dosage form: vial.
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-01

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 69 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-06-28

Patient: 69 year old female, weighing 67.1 kg (147.7 pounds)

Adverse reactions / side effects: Oedema Peripheral, Self-Medication

Suspect drug(s):
Pamabrom 50
    Dosage: qd po
    Administration route: Oral
    Indication: Oedema
    Start date: 2007-06-23
    End date: 2007-06-26

Dyazide
    Dosage: qd po
    Administration route: Oral
    Indication: Oedema
    Start date: 2007-06-26
    End date: 2007-06-26



Adverse event in female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-06-15

Patient: female

Adverse reactions / side effects: Pancytopenia

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 86 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a pharmacist from United States on 2007-05-29

Patient: 86 year old female

Adverse reactions / side effects: Confusional State, Mental Status Changes

Adverse event resulted in: hospitalization

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Synthroid; Boniva; Cartia XT; Lorazepam; CA; Pred



Adverse event in 87 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-04-25

Patient: 87 year old female

Adverse reactions / side effects: Nephrolithiasis, Kidney Infection

Suspect drug(s):
Daraprim
    Indication: Drug USE FOR Unknown Indication

Dyazide
    End date: 1988-01-01



Adverse event in receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-03-02

Patient:

Adverse reactions / side effects: Nausea, Dizziness

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a pharmacist from United States on 2007-01-25

Patient: male, weighing 70.3 kg (154.7 pounds)

Adverse reactions / side effects: Hyperkalaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Allopurinol Sodium; Proscar; Zetia; Norvasc; Fosinopril Sodium



Adverse event in 75 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-01-17

Patient: 75 year old male

Adverse reactions / side effects: Urinary Incontinence

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Lipitor; Toprol-XL

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009